Case Summary (G.R. No. L-4234)
Factual Background
Abbot Laboratories filed a patent application in the Philippines in June 1948 for an invention known as "Tridione." The application claimed priority under Sec. 76 of Rep. Act No. 165 based upon three United States patent applications filed by the inventor Marvin A. Spielman, assignor of the applicant, namely Serial No. 403,073 filed July 18, 1941; Serial No. 630,994 filed November 26, 1945; and Serial No. 779,424 filed October 11, 1947. The application specifically requested that priority rights be granted pursuant to Sec. 76.
Administrative Determination
The Director of Patents denied the request for priority. The Director reasoned that the petitioner's claim for priority had been filed after the date beyond which reciprocal priority rights would obtain between the Philippines and the United States, and therefore the petition was out of time. The Director adopted the view that reciprocal rights under Sec. 76 could be invoked for Americans in the Philippines only up to February 29, 1948.
Executive Correspondence and Its Content
The Director relied upon an exchange of diplomatic notes. The note of the United States Secretary of State dated February 12, 1948 communicated that under the United States laws implementing wartime priority extensions, particularly the Boykin Act, the present expiration date for the extension was February 29, 1948 and that benefits would apply only to cases filed before that date unless Congress provided further extension. The Philippine Ambassador’s note dated August 23, 1948 conveyed that the Philippine Government instructed that the Director of the Philippines Patent Office would regard Sec. 76 as applicable to United States citizens whose patent applications were received at the Philippine Patent Office between June 20, 1947 and February 29, 1948, both dates inclusive, and that the exchange of notes would constitute an agreement between the Republic of the Philippines and the United States on patent matters.
Procedural History
Abbot Laboratories appealed from the Director’s decision to the Supreme Court pursuant to Chapter XIII of Rep. Act No. 165. The appeal principally contested the denial of priority under Sec. 76, asserting that the statutory extension ran until July 1, 1948 and that the Director had no authority to shorten that period by applying the diplomatic exchange.
The Parties’ Contentions
Abbot Laboratories contended that Sec. 76 expressly extended priority rights until July 1, 1948 and that the Director and the Executive Branch lacked power to alter or curtail the statutory period. The petitioner argued that the diplomatic notes amounted to an illegal executive abridgment of a legislative enactment. The Director defended his action by invoking reciprocity and the United States position that Filipinos could receive priority rights in the U.S. only up to February 29, 1948, thereby justifying the parallel limitation for Americans seeking priority in the Philippines.
Legal Issue Presented
The central legal question was whether the exchange of notes between the United States and the Philippines could shorten or otherwise alter the statutory priority period set by Sec. 76 of Rep. Act No. 165, and, relatedly, whether Abbot Laboratories validly claimed priority in June 1948.
Court’s Analysis and Reasoning
The Court found it unnecessary to decide whether a diplomatic agreement could amend a statute. The Court held that the diplomatic notes did not amend or abridge Sec. 76. Instead, the notes constituted an interpretation or application of the statute in the particular relationship between the two countries. The Court reasoned that Sec. 76 is essentially a reciprocity provision. The Secretary of State’s note stated the American law as result: Filipinos could be granted priority rights in the U.S. only if their applications were filed on or before February 29, 1948. The Philippine reply declared that in view of that statement the Philippines Patent Office would likewise regard priority rights as available to Americans only for applications received on or before February 29, 1948. The Court concluded that this construction conformed to the reciprocity purpose of Sec. 76. The Court explained that the statutory phraseology employing three tenses of the verb "extend" signaled that foreigners could invoke priority on or before July 1, 1948 provided Filipinos in the foreign country enjoyed similar rights at the time; it did not require the Director to award priority to a foreigner when Filipinos were not actually afforded
...continue reading
Case Syllabus (G.R. No. L-4234)
Parties and Procedural Posture
- Abbot Laboratories appealed from the decision of Hon. Celedonio Agrava, Director of Patents denying priority on Patent Application Serial No. 77 for an invention known as "Tridione."
- The appeal was taken under the review power provided by Chapter XIII of Rep. Act No. 165.
- The application was submitted in June 1948 by Abbot Laboratories of Illinois and was represented to be assigned to the Philippine applicant.
- The Director of Patents denied the request for priority as untimely, and the Philippine company prosecuted this appeal from that administrative denial.
Key Factual Allegations
- The application recited that the invention was the same as that involved in three United States patent applications by inventor Marvin A. Spielman, the assignor of the applicant.
- The cited U.S. applications were Serial No. 403,073 filed July 18, 1941; Serial No. 630,994 filed November 26, 1945; and Serial No. 779,424 filed October 11, 1947.
- The applicant specifically requested priority under Section 76 of Rep. Act No. 165.
- The Director refused priority on the ground that the Philippine application was filed after February 28, 1948, while the petitioner maintained that the statutory deadline was July 1, 1948.
Statutory Provision
- Section 76, Rep. Act No. 165 extended the rights of priority provided by section nine, Chapter II; section fifteen, Chapter III; and section fifty-six, Chapter XII until July 1, 1948 for citizens of countries which have extended, now extend, or shall extend reciprocal privileges to citizens of the Philippines within the said period.
- The section conditions the extension upon the existence of reciprocity in the foreign country with respect to priority rights.
- The provision employs three tenses in the verb "extend" to indicate that the foreign law granting such privileges may have been adopted before, at, or after the Philippine law, provided reciprocity exists within the period.
Contentions
- Abbot Laboratories contended that the Patent Office illegally shortened the statutory period from July 1, 1948 to February 29, 1948 and that no executive agreement could abridge the period fixed by the Legislature.
- The Director of Patents contended that priority rights were recipr